CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 17,384	$ 14,057
Selling, general and administrative	21,551	20,735
Total operating expenses	38,935	34,792
Loss from operations	(14,146)	(9,848)
Non-operating expense, net:
Foreign exchange loss	(193)	(198)
Interest expense	(1,612)	(1,380)
Other income (expense), net	387	(782)
Total non-operating expense, net	(1,418)	(2,360)
Loss before income taxes	(15,564)	(12,208)
Provision for income taxes	77	76
Net loss	(15,641)	(12,284)
Net loss attributable to noncontrolling interest	(22)
Net loss attributable to Cerus Corporation	$ (15,619)	$ (12,284)
Net loss per share attributable to Cerus Corporation
Basic	$ (0.09)	$ (0.07)
Diluted	$ (0.09)	$ (0.07)
Weighted average shares outstanding:
Basic	178,273	174,478
Diluted	178,273	174,478
Product
Revenue	$ 30,974	$ 37,444
Cost of revenue	13,687	18,076
Gross profit	17,287	19,368
Government Contract
Revenue	$ 7,502	$ 5,576